Home > Insider Trading > Filing (0000950170-24-129830)

Filing Details

Accession Number:: 0000950170-24-129830
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-11-21 18:00:10
Reporting Period:: 2024-11-19

Accepted Time:: 2024-11-21 18:00:10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1880438	An2 Therapeutics Inc.	ANTX	Pharmaceutical Preparations (2834)	820606654

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1914883	Shane Robin Readnour	C/O An2 Therapeutics, Inc. 1800 El Camino Real, Suite D Menlo Park CA 94027		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-11-19	75,000	$1.03	560,073	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2024-11-19	75,000	$1.04	489,788	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2024-11-20	25,000	$1.16	585,073	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2024-11-20	25,000	$1.15	514,788	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Footnotes

This price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $1.0211 to $1.05. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price.
MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC Venture Partners 2018, LP ("MGC 2018 LP") and MGC Venture Partners QP 2018 LP ("MGC 2018 QP"). MGC 2018 GP has shared voting and shared dispositive power over the shares held by MGC 2018 LP and MGC 2018 QP. The Reporting Person is a member of the Issuer's board of directors and is a member of MGC 2018 QP and MGC 2018 LP and a managing partner of MGC 2018 GP and has shared voting power and shared dispositive power over the shares of common stock held by MGC 2018 LP and MGC 2018 QP. The Reporting Person disclaims beneficial ownership of the securities, except to the extent of such person's pecuniary interest in such securities.
Shares held directly by MGC 2018 QP.
This price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $1.0293 to $1.05. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price.
Shares held directly by MGC 2018 LP.